BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6094357)

  • 1. Lymphocytosis-promoting factor of Bordetella pertussis alters mononuclear phagocyte circulation and response to inflammation.
    Meade BD; Kind PD; Manclark CR
    Infect Immun; 1984 Dec; 46(3):733-9. PubMed ID: 6094357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered mononuclear phagocyte function in mice treated with the lymphocytosis promoting factor of Bordetella pertussis.
    Meade BD; Kind PD; Manclark CR
    Dev Biol Stand; 1985; 61():63-74. PubMed ID: 2872133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor.
    Meade BD; Kind PD; Ewell JB; McGrath PP; Manclark CR
    Infect Immun; 1984 Sep; 45(3):718-25. PubMed ID: 6088394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Bordetella pertussis leukocytosis (lymphocytosis)-promoting factor (LPF) on the physical lymphoepithelial-cell association studied with the use of an in vitro model of mouse thymus.
    Sugimoto M; Nakanishi Y; Otokawa M; Uchida N; Yasuda T; Sato H; Sato Y
    J Immunol; 1983 Jun; 130(6):2767-74. PubMed ID: 6682875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mitogenic effect of the lymphocytosis promoting factor from Bordetella pertussis on human T gamma and non-T gamma cells.
    Kashiwa H; Hyodo S; Kishi T; Karakawa T; Kittaka E; Suzawa T; Sakano T; Usui T
    Clin Exp Immunol; 1984 Nov; 58(2):436-43. PubMed ID: 6094059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of Bordetella pertussis lymphocytosis-promoting factor on protective activities of isolated Bordetella antigens in mice.
    Robinson A; Irons LI
    Infect Immun; 1983 May; 40(2):523-8. PubMed ID: 6301999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of lymphoid and nonlymphoid cells with the lymphocytosis-promoting factor of Bordetella pertussis.
    Adler A; Morse SI
    Infect Immun; 1973 Mar; 7(3):461-7. PubMed ID: 4351588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis.
    Morse SI; Morse JH
    J Exp Med; 1976 Jun; 143(6):1483-502. PubMed ID: 58054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of betamethasone in lungs of mice treated with lymphocytosis-promoting factor of Bordetella pertussis.
    Torre D; Quadrelli C; Pugliese A; Maggiolo F
    J Infect Dis; 1986 Aug; 154(2):238-44. PubMed ID: 3722864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis.
    Sato Y; Izumiya K; Sato H; Cowell JL; Manclark CR
    Infect Immun; 1981 Mar; 31(3):1223-31. PubMed ID: 6262248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and biological properties of solubilized envelope proteins of Bordetella pertussis.
    Robinson A; Hawkins DC
    Infect Immun; 1983 Feb; 39(2):590-8. PubMed ID: 6299946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPF-induced T cell colony formation: effect of PMA and interleukin-2, and surface marker analysis.
    Kashiwa H; Hyodo S; Kishi T; Karakawa T; Kittaka E; Suzawa T; Sakano T; Usui T
    Clin Exp Immunol; 1985 Jun; 60(3):509-17. PubMed ID: 3874728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative response of immune mouse T-lymphocytes to the lymphocytosis-promoting factor of Bordetella pertussis.
    Fish F; Cowell JL; Manclark CR
    Infect Immun; 1984 Apr; 44(1):1-6. PubMed ID: 6608495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice.
    Oda M; Cowell JL; Burstyn DG; Manclark CR
    J Infect Dis; 1984 Dec; 150(6):823-33. PubMed ID: 6094673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lymphocytosis-promoting factor from Bordetella pertussis on cerebellar cyclic GMP levels.
    Askelöf P; Gillenius P
    Infect Immun; 1982 Jun; 36(3):958-61. PubMed ID: 6284647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed type hypersensitivity induced by LPF from Bordetella pertussis.
    Guadalupe Cortés JM; Juliano Y; Mendes NF; Mendes E
    Allergol Immunopathol (Madr); 1986; 14(4):311-7. PubMed ID: 2877558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of immunization schedule to standardize antibody response in mice to pertussis vaccines.
    Tiru M; Jäätmaa E; Gillenius P; Askelöf P
    Dev Biol Stand; 1985; 61():469-75. PubMed ID: 2872128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separation and purification of the hemagglutinins from Bordetella pertussis.
    Sato Y; Cowell JL; Sato H; Burstyn DG; Manclark CR
    Infect Immun; 1983 Jul; 41(1):313-20. PubMed ID: 6305841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of Bordetella pertussis lymphocytosis-promoting factor (LPF) on antibody response in mice: its enhancing and suppressive effects.
    Asakawa S; Iwasa S
    Jpn J Med Sci Biol; 1982 Feb; 35(1):25-9. PubMed ID: 6285047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocytosis-promoting factor of Bordetella pertussis: isolation, characterization, and biological activity.
    Morse SI
    J Infect Dis; 1977 Aug; 136 Suppl():S234-8. PubMed ID: 197175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.